| __timestamp | Bristol-Myers Squibb Company | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 152500000 |
| Thursday, January 1, 2015 | 5920000000 | 187800000 |
| Friday, January 1, 2016 | 4940000000 | 184000000 |
| Sunday, January 1, 2017 | 6411000000 | 167700000 |
| Monday, January 1, 2018 | 6345000000 | 218600000 |
| Tuesday, January 1, 2019 | 6148000000 | 187400000 |
| Wednesday, January 1, 2020 | 11143000000 | 177700000 |
| Friday, January 1, 2021 | 10195000000 | 122000000 |
| Saturday, January 1, 2022 | 9509000000 | 123100000 |
| Sunday, January 1, 2023 | 9299000000 | 122500000 |
| Monday, January 1, 2024 | 11159000000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Bristol-Myers Squibb Company has consistently outpaced Perrigo Company plc in R&D investments. From 2014 to 2023, Bristol-Myers Squibb increased its R&D spending by over 100%, peaking in 2020 with a remarkable 11% of its revenue dedicated to R&D. In contrast, Perrigo's R&D expenditure remained relatively flat, averaging around 1% of its revenue annually. This stark difference highlights Bristol-Myers Squibb's strategic focus on pioneering new treatments and therapies, while Perrigo maintains a more conservative approach. As the pharmaceutical industry continues to evolve, these investment strategies may significantly impact each company's ability to innovate and capture market share.
R&D Spending Showdown: Novartis AG vs Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Genmab A/S or Perrigo Company plc: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Perrigo Company plc and Xenon Pharmaceuticals Inc.